Diabetes
Quiz yourself by thinking what should be in
each of the black spaces below before clicking
on it to display the answer.
Help!
|
|
||||
---|---|---|---|---|---|
Glucagon | Stimulate glycolysis; Stimulate hepatic gluconeogenesis and ketogenesis
🗑
|
||||
Insulin | Stimulate Glu uptake by muscles and adipose tissue; Suppress glucagon secretion; Stimulate glycogen, protein, and fat synthesis; Stimulate Glu use as energy
🗑
|
||||
Amylin | Suppress glucagon secretion; Slow gastric emptying; Reduce food intake and body weight
🗑
|
||||
GLP-1 | Stimulate Glu-dependent insulin release; Suppress glucagon secretion; Slow gastric emptying; Reduce food intake and body weight; Promote beta-cell health
🗑
|
||||
ADA | American Diabetes Association
🗑
|
||||
AACE/ACE | American Association of Clinical Endocrinologists/American College of Endocrinology
🗑
|
||||
Diagnostic criteria for Pre-DM | Fasting: 100-125
Postprandial: 140-199
A1C: 5.7-6.4% (ADA) or 5.5-6.4% (AACE)
🗑
|
||||
ADA Targets | Fasting: 80-130
Postprandial: <180
A1C: 7%
🗑
|
||||
AACE/ACE Targets | Fasting: <110
Postprandial: <140
A1C: <6.5%
🗑
|
||||
DCCT | T1DM: Aggressive Glu control (>3 shots/day or pump) decreases microvascular complications
🗑
|
||||
UKPDS | T2DM: Each 1% decrease in A1C = 35% reduction in microvascular complications; No impact on macrovascular; Metformin decreased macrovascular risk in obese populations
🗑
|
||||
ACCORD | T2DM: Ended early due to increased rate of mortality in intensive glycemic control group (A1C <6%)
🗑
|
||||
ADVANCE | T2DM: Intensive control (A1C <6.5%) decreased risk of renal events, but no difference in major macrovascular events
🗑
|
||||
VADT | T2DM: No difference in macrovascular events or mortality
🗑
|
||||
Macrovascular | Brain (stroke)
Heart (CAD)
Extremities (PVD)
🗑
|
||||
Microvascular | Eyes (retinopathy)
Kidney (nephropathy)
Nerves (neuropathy)
🗑
|
||||
HTN Management | Screening: annually
Goal: <140/90
Treatment: lifestyle modifications and ACEI/ARB
🗑
|
||||
Lipid Management | Screening: at diagnosis and every 5 years
Treatment: <40 and no risk factors = none; >40 and no risk factors = moderate; risk factors or ASCVD = high
🗑
|
||||
High intensity statins | Atorvastatin 40-80 mg
Rosuvastatin 20-40 mg
🗑
|
||||
Antiplatelet Therapy | Primary Px: ASA if >50 + risk factor(s)
Secondary Px: ASA 75-162 mg/day
🗑
|
||||
Nephropathy | Screening: annually
Goal: urine albumin/Cr <30
Treatment: ACEI/ARB; protein restriction (0.8 g/kg/day)
🗑
|
||||
Peripheral Neuropathy | Screening: annual w/monofilament
Treatment: TCAs, gabapentin, pregabalin, duloxetine, tapentadol
🗑
|
||||
Retinopathy | Screening: annual w/dilation
Treatment: refer to ophthalmologist
🗑
|
||||
Immunizations | Annual flu vaccine
Pneumococcal vaccine
Hepatitis B vaccine
🗑
|
||||
NICE-SUGAR | Inpatient DM: Less stringent Glu control (<180) had decreased mortality and decreased hypogylcemia
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
kcapizzi
Popular Pharmacology sets